<DOC>
	<DOC>NCT02243696</DOC>
	<brief_summary>The purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.</brief_summary>
	<brief_title>Protego DF4 Post Approval Registry</brief_title>
	<detailed_description />
	<criteria>Implanted within the last 30 days or candidate for implantation of a BIOTRONIK ICD or CRTD DF4 compatible system along with the Protego DF4 lead Meets ICD or CRTD system implant recommendations as defined in guidelines published by relevant professional societies Able to understand the nature of the registry and provide informed consent Available for followup visits on a regular basis at the investigational site for the expected 5 years of followup Age greater than or equal to 18 years Enrolled in any investigational cardiac device trial Planned cardiac surgical procedures or interventional measures within the next 6 months Expected to receive heart transplantation or ventricular assist device within 1 year Life expectancy of less than 1 year Presence of another lifethreatening, underlying illness separate from their cardiac disorder Patients reporting pregnancy at the time of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>